SFW Capital Partners Completes Majority Recapitalization of Pion Inc.

SFW Capital Recapitalizes Caron Products and Services

January 13, 2021

Medical Devices

SFW Capital Partners completed a strategic recapitalization of Caron Products and Services, partnering with Caron CEO Steve Keiser and VP Dave Figel who remain significant shareholders. The recapitalization will fund expansion of Caron’s product portfolio, enhancement of sales, marketing and service capabilities, and support inorganic growth through acquisitions.

SFW Capital Partners Recapitalizes Micromeritics Instrument Corporation

December 19, 2019

Manufacturing

SFW Capital Partners completed a strategic recapitalization of Micromeritics Instrument Corporation, partnering with Micromeritics President Preston Hendrix and his family, who will remain significant shareholders. The deal brings SFW resources and leadership (Terry Kelly named CEO) to support product development, sales and service expansion, and pursuit of strategic add-on acquisitions.

SFW Capital Partners Majority Recapitalizes RDI Technologies

February 17, 2022

Industrial Services

SFW Capital Partners completed a majority recapitalization of RDI Technologies, with founder and senior management reinvesting to retain a meaningful equity stake. RDI, a Knoxville-based provider of vision-based analytical solutions for predictive maintenance and test & measurement, will partner with SFW to accelerate growth, expand product and sales capabilities, pursue add-on acquisitions, and build an international footprint.

Pion Inc Acquires Two Square Science

December 11, 2022

Medical Devices

Pion Inc., a provider of analytical instruments for drug development and backed by SFW Capital, has acquired Two Square Science, a Fall River, Massachusetts company that designs sample preparation and lab monitoring equipment. The acquisition adds Two Square's PrepEngine and LabEye technologies to Pion's product portfolio to expand in vitro sample preparation and remote monitoring capabilities and accelerate customers' drug development workflows.

SFW Capital Partners Makes Strategic Investment in Sannova Analytical

August 10, 2022

Biotechnology

SFW Capital Partners completed a strategic growth investment in Sannova Analytical, a Somerset, New Jersey-based bioanalytical CRO that provides bioanalytical and CMC testing services to pharmaceutical and biotech companies. Founders and existing owners (including the Marepalli family, Dr. Venkat Reddy, Malleswar Kollu, and Geeta Vidiyala) are reinvesting and retaining an equity stake; SFW will support expansion of services, capacity, and pursue strategic acquisitions to accelerate growth.

SFW Capital Partners Completes Majority Investment in Captify Technologies

July 14, 2021

Marketing & Advertising

SFW Capital Partners completed a majority investment in Captify Technologies Ltd., a London-based privacy-first search intelligence and marketing data platform. Terms were not disclosed; existing investors and management are reinvesting and SFW will support Captify's growth and expansion of its cookieless search intelligence offerings.